ClinConnect ClinConnect Logo
Search / Trial NCT06002373

Assessment of Artificial Intelligence for Treatment Decision Recommendation of Adult Skeletal Class III Patients

Launched by CAIRO UNIVERSITY · Aug 13, 2023

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the use of artificial intelligence (AI) to help make treatment decisions for adults with a specific dental condition called skeletal Class III malocclusion. This condition means that the lower jaw is either too big or the upper jaw is underdeveloped, which can cause problems with how the teeth fit together and affect facial appearance. The researchers want to see if AI can accurately suggest the best treatment options and if these suggestions match what experienced orthodontists would recommend.

To participate in this study, individuals must be adults who have already completed their growth and have skeletal Class III malocclusion, but they should not have any other major health conditions or previous jaw surgeries that could complicate their treatment. Participants will provide their dental records and undergo assessments, and in return, they will help researchers understand how reliable AI can be in guiding orthodontic care. If the trial shows that AI can make accurate recommendations, it could lead to quicker and more standardized treatment options for patients with this condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Skeletally mature patients with CVMI 6.
  • Skeletal class III patients
  • No congenital deformity, syndrome, or cleft.
  • No previous surgical intervention
  • No mandibular transverse functional shift.
  • Normal overjet, overbite after completion of treatment.
  • Patients with well finished occlusion.
  • Patients who have achieved adequate functional and aesthetic results at the end of their treatment.
  • Good quality initial and final lateral cephalometric radiographs.
  • No sex predilection.
  • Exclusion Criteria:
  • Adolescents and skeletally immature patients.
  • Patients with pseudo class III.
  • Syndromic patients.
  • Patients with facial deformity at the naso-maxillary complex

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Cairo, , Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported